Insulin Autoantibodies (IAA) and the effect of royal jelly on Type 1 diabetic patients
المهدي محمد علي المهدي, تماضر علي محمد ابراهيم
كلية العلوم-جامعة الخرطوم · السودان
The main objective of measurement of insulin autoantibodies (IAA) in this study is to identify the level of these autoantibodies in patients under good insulin metabolic control and those under poor insulin metabolic control. Results revealed that most of them (group B2) were under poor insulin metabolic control 64.3% patients compared to 35.7 % patients (B1) who were under good insulin metabolic control. The difference was statistically significant (p =0.00) The second objective was to assess the effect of a daily dose of royal jelly for a period of 3 months on diabetic patients. The reference tests for diabetes mellitus were applied and that by detecting glucose level in blood and urine on fasting and postprandial fortnightly in two groups namely group A (control) and group B (study). Results showed no significant difference between 2 groups with respect to these tests. Mean fasting plasma glucose level in group B which received royal jelly was 216.83± 63.20mg/dl compared to 276.94± 62.30mg/dl for group A(p =0.00). Results of mean postprandial glucose level was significantly different for the study group (p = 0.00). Similarly fasting urine glucose level for the study group was significantly different compared to control group (p=0.001